Received Jul 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
lymph nodes remained inflamed for weeks after the vaccine; This is a spontaneous report received from a Consumer or other non HCP from a sales representative. An adult female patient (unknown if pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "drug allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: LYMPHADENITIS (non-serious), outcome "recovered", described as "lymph nodes remained inflamed for weeks after the vaccine". It was unknown if therapeutic measures were taken as a result of lymphadenitis. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Drug allergy